share_log

Profound Medical Q1 2024 GAAP EPS $(0.26) Beats $(0.30) Estimate, Sales $1.910M Miss $2.521M Estimate

Benzinga ·  May 9 16:50

Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.30) by 13.33 percent. This is a 18.75 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $1.910 million which missed the analyst consensus estimate of $2.521 million by 24.24 percent. This is a 2.69 percent increase over sales of $1.860 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment